Zoetis Inc. (NYSE:ZTS) management will conduct a conference call for 5th November 2020 at 8:30 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.zoetis.com
Earnings Expectation
Zoetis Inc. is reporting third quarter financial results on Thursday 5th November 2020, before market open.
According to analysts surveyed by Thomson Reuters, ZTS is expected to report 3Q20 income of $ 0.91 per share from revenue of $ 1627.20 million.
For the full year, analysts anticipate top line of $ 6432.14 million, while looking forward to income of $ 3.64 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 5,950.00 million ~ $ 6,250.00 million, where as bottomline are predicted in a range of $ 3.17 ~ $ 3.42 per share
Click Here For More Historical Outlooks Of Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
